These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25466629)

  • 1. Type I IFN--a blunt spear in fighting HIV-1 infection.
    Acchioni C; Marsili G; Perrotti E; Remoli AL; Sgarbanti M; Battistini A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):143-58. PubMed ID: 25466629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between Intrinsic and Innate Immunity during HIV Infection.
    Bergantz L; Subra F; Deprez E; Delelis O; Richetta C
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
    Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
    PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early IFN type I response: Learning from microbial evasion strategies.
    Coccia EM; Battistini A
    Semin Immunol; 2015 Mar; 27(2):85-101. PubMed ID: 25869307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.
    Sandstrom TS; Ranganath N; Angel JB
    Cytokine Growth Factor Rev; 2017 Oct; 37():1-16. PubMed ID: 28455216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 evades innate immune recognition through specific cofactor recruitment.
    Rasaiyaah J; Tan CP; Fletcher AJ; Price AJ; Blondeau C; Hilditch L; Jacques DA; Selwood DL; James LC; Noursadeghi M; Towers GJ
    Nature; 2013 Nov; 503(7476):402-405. PubMed ID: 24196705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate antiviral immune signaling, viral evasion and modulation by HIV-1.
    Rustagi A; Gale M
    J Mol Biol; 2014 Mar; 426(6):1161-77. PubMed ID: 24326250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity against HIV-1 infection.
    Altfeld M; Gale M
    Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and utility of innate immune system evasion mechanisms of ASFV.
    Correia S; Ventura S; Parkhouse RM
    Virus Res; 2013 Apr; 173(1):87-100. PubMed ID: 23165138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.
    Scagnolari C; Antonelli G
    Cytokine Growth Factor Rev; 2018 Apr; 40():19-31. PubMed ID: 29576284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.
    Doehle BP; Chang K; Fleming L; McNevin J; Hladik F; McElrath MJ; Gale M
    J Virol; 2012 Aug; 86(16):8499-506. PubMed ID: 22647704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensor Sensibility-HIV-1 and the Innate Immune Response.
    Yin X; Langer S; Zhang Z; Herbert KM; Yoh S; König R; Chanda SK
    Cells; 2020 Jan; 9(1):. PubMed ID: 31968566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells.
    Zahoor MA; Xue G; Sato H; Aida Y
    Virus Res; 2015 Oct; 208():156-63. PubMed ID: 26116899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and interferon regulatory factor 1: a story of manipulation and control.
    Sivro A; Su RC; Plummer FA; Ball TB
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1428-33. PubMed ID: 23984938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danger, diversity and priming in innate antiviral immunity.
    Collins SE; Mossman KL
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):525-31. PubMed ID: 25081316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
    Delaloye J; Filali-Mouhim A; Cameron MJ; Haddad EK; Harari A; Goulet JP; Gomez CE; Perdiguero B; Esteban M; Pantaleo G; Roger T; Sékaly RP; Calandra T
    J Virol; 2015 Apr; 89(7):3819-32. PubMed ID: 25609807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication.
    Berg RK; Rahbek SH; Kofod-Olsen E; Holm CK; Melchjorsen J; Jensen DG; Hansen AL; Jørgensen LB; Ostergaard L; Tolstrup M; Larsen CS; Paludan SR; Jakobsen MR; Mogensen TH
    PLoS One; 2014; 9(1):e84513. PubMed ID: 24404168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.